ETON

Eton Pharmaceuticals Inc

3.87
-0.02 (-0.51%)

Eton Pharmaceuticals Inc. (ETON) Fundamentals

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has a diversified pipeline of around eleven product candidates in various stages of development.
SHARE INFORMATION
Market CapUS$ 99,212,030
Shares Outstanding25,504,378
Float22,170,000
Percent Float86.93%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 5,304,000
Latest Fiscal EPSUS$ -100.00
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions70
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months109,896
Institutional Holdings Percent36.0%
Institutional Sold Previous 3 Months363,837
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months550,467
Insider Holdings Percent7.7
Insider Sold Previous 3 Months-
Insider Shares Owned1,951,881
TRADING INFO
52 Week HighUS$ 4.28
52 Week LowUS$ 1.95
52 Week High ChangeUS$ 28.38
21 Day Moving AverageUS$ 3.758
21 Day Extended Moving AverageUS$ 3.7885
50 Day Moving AverageUS$ 3.6717
50 Day Extended Moving AverageUS$ 3.7155
200 Day Moving AverageUS$ 3.1451
200 Day Extended Moving AverageUS$ 3.4679
10 Day Average Volume46,726
20 Day Average Volume44,680
30 Day Average Volume41,273
50 Day Average Volume39,892
Alpha-0.011682
Beta1.4427
Standard Deviation0.144432
R20.306859
7 Day Price ChangeUS$ -0.01
7 Day Percent Change-0.26%
21 Day Price ChangeUS$ 0.26
21 Day Percent Change7.16%
30 Day Price ChangeUS$ 0.42
30 Day Percent Change12.1%
Month to Date Price ChangeUS$ -0.07
Month to Date Percent Change-1.77%
Quarter to Date Price ChangeUS$ 0.04
Quarter to Date Percent Change1.04%
180 Day Price ChangeUS$ 0.82
180 Day Percent Change26.71%
200 Day Price ChangeUS$ 0.87
200 Day Percent Change28.81%
Year to Date Price ChangeUS$ 1.07
Year to Date Percent Change37.94%

Eton Pharmaceuticals Inc. (ETON) Key Ratios

PROFITABILITY
EBIT Margin-23.4%
EBITDA Margin-15.8%
Pre-Tax Profit Margin-141.0%
Profit Margin Count-0.5%
Gross Margin66.5%
Profit Margin TOT-0.5%
INCOME STATEMENTS
RevenueUS$ 5,304,000
Revenue Per ShareUS$ 0.208
Revenue (3 Years)US$ 0.00
Revenue (5 Years)US$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book14.70
Total Debt To Equity0.60
Int Coverage0.00
Current Ratio2.60
Leverage Ratio2.10
Quick Ratio2.40
Long Term Debt To Capital0.32
VALUATION MEASURES
PE Ratio0.00
Enterprise ValueUS$ 90,270,899
Price to Sales4.00
Price to Free Cash298.60
PE High Last 5 Years0.00
Price To Book8.70
Price To Cash Flow-15.80
PE Low Last 5 Years0.00
Price to Tangible Book14.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover13.30
Invoice Turnover17.30
Assets Turnover1.00
Return Assets-26.99
Return on Equity75.74
Return on Capital-30.45

Eton Pharmaceuticals Inc. (ETON) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
Auditor-
CEOSean Brynjelsen
Employees17
Last Audit-
CIK0001710340
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address21925 West Field Parkway,Suite 235
Suite 235
Deer Park, IL 60010-7278
Websitehttps://www.etonpharma.com
Facsimile-
Telephone+1 847 787-7361
Email-
Your Recent History
NASDAQ
ETON
Eton Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230610 15:36:17